Literature DB >> 25314089

Increasing LARC utilization: any woman, any place, any time.

Mark Hathaway1, Leah Torres, Jennifer Vollett-Krech, Hannah Wohltjen.   

Abstract

Intrauterine contraceptive devices and the progestin implant are the most effective long-acting reversible contraception (LARC) methods available for preventing unintended pregnancy. LARC devices are safe, non-user-dependent methods that have the highest rates of continuation and satisfaction of all reversible contraceptives. Use of these contraceptives remains low in the United States due to several barriers including: misperceptions among both providers and patients; cost barriers; and patient access to the devices. Increasing the opportunities for women to access LARC methods in the primary care, postabortion, and postpartum setting can be achieved by addressing the system, provider, and patient barriers that exist.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314089     DOI: 10.1097/GRF.0000000000000071

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  14 in total

1.  Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.

Authors:  Christine Troskie; Judith A Soon; Arianne Y Albert; Wendy V Norman
Journal:  CMAJ Open       Date:  2016-11-03

Review 2.  Pregnancy Intention-More Important Than Ever.

Authors:  Susan B Moskosky
Journal:  Public Health Rep       Date:  2016-08-22       Impact factor: 2.792

3.  Improving LARC Access for Urban Adolescents and Young Adults in the Pediatric Primary Care Setting.

Authors:  Uche F Onyewuchi; Kathy Tomaszewski; Krishna K Upadhya; Priya S Gupta; Natalie Whaley; Anne E Burke; Maria E Trent
Journal:  Clin Pediatr (Phila)       Date:  2018-10-13       Impact factor: 1.168

4.  Postpartum Contraceptive Use Among Denver-Based Adolescents and Young Adults: Association with Subsequent Repeat Delivery.

Authors:  Margo S Harrison; Rachel Zucker; Sharon Scarbro; Carter Sevick; Jeanelle Sheeder; Arthur J Davidson
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-04-03       Impact factor: 1.814

5.  Trends in Long-Acting Reversible Contraception Use in Adolescents and Young Adults: New Estimates Accounting for Sexual Experience.

Authors:  Karen Pazol; Kimberly Daniels; Lisa Romero; Lee Warner; Wanda Barfield
Journal:  J Adolesc Health       Date:  2016-07-19       Impact factor: 5.012

6.  State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies.

Authors:  Charlan D Kroelinger; Isabel A Morgan; Carla L DeSisto; Cameron Estrich; Lisa F Waddell; Christine Mackie; Ellen Pliska; David A Goodman; Shanna Cox; Alisa Velonis; Kristin M Rankin
Journal:  J Womens Health (Larchmt)       Date:  2018-11-02       Impact factor: 2.681

Review 7.  Reforming Women's Health Care: A Call to Action for Lifestyle Medicine Practitioners to Save Lives of Mothers and Infants.

Authors:  Janani Krishnaswami; Maria Del C Colon-Gonzalez
Journal:  Am J Lifestyle Med       Date:  2019-04-08

8.  Immediate Postpartum Long-Acting Reversible Contraception Programs in Texas Hospitals Following Changes to Medicaid Reimbursement Policy.

Authors:  Ashley V Hill; Eileen Nehme; Nagla Elerian; Ella D Puga; Brandie D Taylor; David Lakey; Divya A Patel
Journal:  Matern Child Health J       Date:  2019-12

9.  Does counselling improve uptake of long-term and permanent contraceptive methods in a high HIV-prevalence setting?

Authors:  Amon Siveregi; Lilian Dudley; Courage Makumucha; Phatisizwe Dlamini; Sihle Moyo; Sibongiseni Bhembe
Journal:  Afr J Prim Health Care Fam Med       Date:  2015-11-06

10.  Understanding Factors Associated with Postpartum Visit Attendance and Contraception Choices: Listening to Low-Income Postpartum Women and Health Care Providers.

Authors:  Vida Henderson; Katrina Stumbras; Rachel Caskey; Sadia Haider; Kristin Rankin; Arden Handler
Journal:  Matern Child Health J       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.